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Atrial natriuretic peptide and furosemide effects on hydraulic pressure
in the renal papilla. Atrial peptides (ANP) have been shown to prefer-
entially increase blood flow tojuxtamedullary nephrons and to augment
vasa recta blood flow. To determine the effect of this alteration in
intrarenal blood flow distribution on pressure relationships in inner
medullary structures and their significance as a determinant of ANP-
induced natriuresis, we measured hydraulic pressures in vascular and
tubule elements of the renal papilla exposed in Munich-Wistar rats in
vivo during an euvolemic baseline period and again during an experi-
mental period. Rats in Group 1 received intravenous infusion of rANP
[4-27], administered as a 4 sg/kg prime and 0.5 gIkg/min continuous
infusion, and were maintained euvolemic by plasma replacement.
Infusion of ANP resulted in significant natriuresis, diuresis and increase
in inulin clearance. Within 90 seconds of initiation of this systemic
infusion, vasa recta hydraulic pressures were markedly increased and
exceeded the small pressure increment occurring in loops of Henle and
collecting ducts. Infusion of furosemide in Group 2 rats at a dosage
which reproduced the increase in urine flow in Group I was associated
with small and equivalent increases in both vascular and tubule ele-
ments, indicating that the differential pressure response observed in
Group 1 was not due to increased tubule fluid flow rates, but was rather
a specific ANP-induced vascular effect. Group 3 rats received an
infusion of ANP in a setting where its whole kidney hemodynamic
effects were prevented. This resulted in a marked blunting of natriuresis
and diuresis, and obliteration of the pressure differential between vasa
recta and tubules observed in Group I. Thus, the hydraulic pressure
imbalance between papillary vascular and tubule structures occurring
during infusion of ANP in euvolemic Group I rats may impede fluid
reabsorption from local papillary interstitium, and thereby serve as an
important mechanism of ANP-induced natriuresis and diuresis.
Several mechanisms have been suggested to contribute to the
augmentation of renal sodium excretion occurring in response
to infusions of atrial natriuretic peptides (ANP). These have
included an increase in the glomerular filtration rate (GFR)
[1, 2], an alteration of intrarenal blood flow distribution toward
juxtamedullary nephrons with attendant "medullary washout"
[3, 4], and direct inhibitory effects on tubule sodium transport in
proximal [5, 6] and terminal nephron segments [7, 81.
The relative importance of these diverse ANP effects remains
unclear. It is evident, however, that renal hemodynamic actions
of ANP are important determinants of the natriuretic response
to ANP infusions. Lowering of renal perfusion pressure by
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pre-renal arterial clamping prior to, or during, ANP administra-
tion has been shown to markedly blunt or abolish the natriuresis
[1,9,4]. Since clamping also prevented an ANP-induced rise in
GFR, the enhancement of GFR by ANP was felt to be a primary
factor responsible for its natriuretic effect [11. However, several
studies have demonstrated increases in renal sodium excretion
in the absence of discernable changes in whole kidney hemo-
dynamics [6, 7, 10]. On the other hand, an additional hemody-
namic mechanism which might be operative lies in the renal
vasodilatory properties of ANP, in particular its ability to
increase vasa recta blood flow [11, 10]. Such actions could give
rise to alterations in medullary vasa recta Starling forces, which
in turn could influence sodium excretion by altering capillary
uptake of reabsorbate in this region.
The present studies were therefore undertaken to character-
ize the inner medullary hemodynamic response to infusion of
ANP. This response was compared to infusion of a direct
inhibitor of epithelial sodium transport, furosemide, and to
infusion of ANP in a setting where its hemodynamic effects
were suppressed.
Methods
Three groups of male Munich-Wistar rats (Simonson Labo-
ratory, Gilroy, California, USA) weighing 89 to 122 g were
employed in these studies. All animals were allowed free access
to standard rat chow (Rodent Laboratory Chow #5001, Ralston
Purina Co., Richmond, Indiana, USA) and tap water.
Micropuncture studies
Rats were anesthetized with mactin (100 mg/kg, i.p.; Byk
Gulden, Konstanz, FRG) and positioned on a temperature
regulated table. Following tracheostomy, a polyethylene cath-
eter (PE-50) was inserted into the left femoral artery for
periodic blood sampling and for monitoring of mean arterial
pressure (AP) via an electronic transducer (Model P23Db,
Statham Instruments Division, Gould Inc., Oxnard, California,
USA) coupled to a direct-writing recorder (Model 7754A,
Hewlett-Packard Co., Palo Alto, California, USA). Catheters
(PE-50) were also inserted into the left femoral vein for infusion
of plasma and into the right and left jugular veins for infusion of
inulin/para-aminohippurate (PAH) and experimental agents,
respectively. To prevent net loss of plasma volume during
preparation for micropuncture, all rats received an intravenous
infusion of isoncotic rat plasma equivalent to 1% of body weight
36
Méndez et a!: ANP/furosemide and papillary hemodynamies 37
over 45 minutes, after which the infusion rate was reduced to
1.5 mI/kg/hr. A similar protocol has been shown to maintain
hematocrit at pre-anesthesia levels in Munich-Wistar rats of
comparable age during micropuncture [121. All animals also
received a continuous infusion of 0.9% NaCI containing 3%
inulin and 0.8% PAH at the rate of 0.41 mI/hr. Following
midline and left subcostal incisions, the right ureter was can-
nulated with PE-lO tubing, and the left kidney was suspended
on a glass holder and bathed continuously with warmed 0.9%
NaC1, The left ureter was carefully dissected to provide full
exposure of the renal papilla (1.5 to 2.5 mm), which was
transilluminated with a fiber-optic light source and also bathed
continuously with warmed 0.9% NaCI.
After allowing 60 minutes for equilibration following the
reduction in plasma infusion rate, baseline clearance and mi-
cropuncture measurements were begun. Urine from the right
kidney was collected at 10 to 20 minute intervals for measure-
ment of urine flow rate (V) and concentrations of sodium,
inulin, and PAH. Femoral arterial blood samples were obtained
at the midpoint of each urine collection for determination of
inulin and PAH concentrations. Time-averaged hydraulic pres-
sures were measured in one to three descending and ascending
vasa recta, loops of Henle, and collecting ducts in each animal
at accessible points between base and tip of the exposed renal
papilla with a continuously recording, servo-nulling system
(Model 3, Instrumentation for Physiology and Medicine, San
Diego, California, USA) which employed 2 to 3 im (outer tip
diameter) micropipettes filled with 2.0 M NaCI. In this study the
base refers to the portion of the exposed papilla nearest to the
kidney whereas the tip refers to the opposite end. Hydraulic
output from the servo system was coupled electronically to a
second channel of the Hewlett-Packard recorder by means of a
pressure transducer (Statham Model P23Db).
Group I (N = 6)
Following completion of baseline clearance and micropunc-
ture measurements (30 to 40 mm), synthetic rat ANP [4-27]
(Peninsula Laboratories, Belmont, California, USA) in 0.9%
NaCI was infused intravenously as a 4 pg/kg priming dose (0.07
ml) over a two minute interval, followed by a sustaining Lv.
infusion at the rate of 0.5 g/kgImin (0.58 mI/hr). The plasma
infusion rate was increased to 0.01 mi/mm concurrently with
ANP infusion in an attempt to maintain the euvolemic state.
This rate was found in pilot studies to maintain a constant
hematocrit during infusion of ANP. Clearance studies during
this experimental period were begun three to five minutes after
completion of the ANP priming dose. This time interval allowed
maximal urine flow rates to be achieved and thereby obviated
urinary dead-space artifact during the transition from low to
high urine flow rates. Hydraulic pressure measurements in
papillary vascular and tubule elements were repeated in random
order at the same sites sampled during the control period (for
90% of the determinations), beginning 10 minutes after the
initiation of the priming ANP dose and ending approximately 20
minutes later.
Group 2 (N = 7)
These rats were subjected to an identical protocol as detailed
for Group 1 except that, instead of ANP, an intravenous
infusion of furosemide (Lasix, Hoechst Pharmaceuticals, Som-
erville, New Jersey, USA) in 0.9% NaC1 was administered
during the experimental period as 0.2 mg/kg prime (0.07 ml)
over a two minute interval, followed by a continuous i.v.
infusion at the rate of 0.3 to 0.4 mg/kg/hr (0.58 ml/hr). This
dosage was selected to reproduce the increase in urine flow rate
observed during ANP infusion in the previous group and thus
served as control for increases in tubule hydraulic pressure
observed during diuresis [131.
In a single rat from each of these groups it was possible to
position the pressure pipette within a descending vas rectum in
a secure fashion such that it could be kept in place for several
minutes during initiation of the priming dose of ANP or furo-
semide, thereby providing a continuous recording of the acute
effects of these agents on vasa recta hydraulic pressure.
Group 3 (N = 7)
Rats in this group followed an Identical protocol as those in
Group 1, except that the plasma infusion rate was not increased
until four to five minutes after the ANP priming dose had been
given and the sustaining infusion had begun. This protocol was
found in preliminary studies to be associated with unchanged
whole kidney GFR and a modest increase in urinary sodium
excretion (UNaV).
Chemical analyses and calculations
Urine sodium concentration was measured by flame photom-
etry (Model 443, Instrumentation Laboratory, Lexington, Mas-
sachusetts, USA). The concentrations of inulin and PAH in
plasma and urine were determined, respectively, by a macro-
anthrone method [14] and by a colorimetric technique [15].
Postglomerular plasma oncotic pressure was calculated by
standard formulas as previously described [161. A value of 4.9
mg/dl for systemic plasma protein concentration was used for
these calculations, a value obtained for the baseline period in
rats of comparable age (N = 11), and assuming no change
during the experimental period.
Statistical analysis
All results are expressed as means SEM. Statistical analyses
were performed using one-way analysis of variance and paired
i-tests, where appropriate. If the one-way analysis of variance
determined the presence of differences between groups, a t-test
using the Bonferroni modification for three preplanned compar-
isons was applied to determine significance [17]. Statistical
significance was defined as P <0.05.
Results
Baseline period
Mean values for the parameters studied in this initial period
were similar in all three groups. Hydraulic pressures in de-
scending vasa recta were slightly higher (9.1 0.3, 8.4 0.5,
9.6 0.2 mm Hg; groups 1, 2, and 3, respectively) than in
ascending vasa recta (7.8 0.6, 7.8 0.4, 8.1 0.3 mm Hg;
groups 1, 2, and 3, respectively), the axial gradient thus
favoring forward blood flow. Hydraulic pressures similar to
those of ascending vasa recta were found in loops of Henle (7.8
0.4, 7.3 0.3, 8.3 0.5 mm Hg; groups 1, 2, and 3,
respectively), while correspondingly lesser values were mea-
sured at the base (5.2 0.3, 4.5 0.2, 4.4 0.1 mm Hg) and
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mid-portion of the collecting duct (3.1 0.5, 2.8 0.3, 2.8
0.2 mm Hg), with the axial pressure gradient in these structures
again favoring forward flow of tubule fluid.
Experimental period
Group 1. As depicted in Figure 1, ANP infusion in this group
of rats resulted in a more than 23-fold increase in UNaV in the
setting of a 15 mm Hg reduction in AP (Fig. 2). This natriuretic
response resulted not only from an elevation of V (from 1.4
0.1 to 7.5 0.8 p1/mm, P < 0.05), but also from a marked rise
in urine sodium concentration to substantially hypernatric
levels (UNa, from 54 5 to 253 6 mEq/liter, P < 0.05). Whole
kidney inulin clearance, (C1, Fig. 3), a measure of GFR,
increased significantly, on average by 21% over baseline values,
while effective renal plasma flow (RPF), estimated from the
PAH clearance (CpAH), was largely unaffected (1.56 0.06 and
1.68 0.07 ml/min, baseline and experimental periods, respec-
tively). Hydraulic pressures in both vascular and tubule struc-
tures of the exposed renal papilla were significantly increased
during infusion of ANP. Hydraulic pressures in tubule elements
increased by approximately 2 mm Hg, on average in loops of
Henle from 7.8 0.4 to 10.1 0.7 mm Hg, at the collecting
duct base from 5.2 0.3 to 7.1 0.3 mm Hg, and at the
mid-portion of the exposed collecting duct from 3.1 0.5 to 5.2
0.4 mm Hg. In contrast, the increment in vasa recta hydraulic
pressures was much more marked, approximately threefold
higher, than that observed in tubule elements, increasing on
average in descending vasa recta from 9.1 0.3 to 15.5 1.0
mm Hg and in ascending vasa recta from 7.8 0.6 to 14.3 0.8
mm Hg (Figs. 4 and 5). Continuous recording in a descending
vas rectum from the initiation of ANP administration showed
that hydraulic pressure had increased immediately and progres-
sively from 11 mm Hg to a maximum of 17 mm Hg within 90
seconds of beginning the ANP infusion. Time course determi-
nation of V in a single separate rat showed that V had
approximately doubled within two minutes after initiation of the
ANP prime (from 1.5 to 3.3 p1/mm).
Group 2. Infusion of furosemide in Group 2 animals repro-
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Fig. 1. Urinary sodium excretion (UNaV) in Groups 1(0), 2 (•), and3
(A) during baseline and experimental periods. Values are expressed as
means 1 SEM; * P < 0.05 vs. baseline, t P < 0.05 vs. group 2, P <
0.05 vs. group 3.
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Fig. 2. Mean systemic arterial pressure () in Groups 1 (0), 2 (•),
and 3 (A) during baseline and experimental periods. Values are
expressed as means I sEM; * P < 0.05 vs. baseline.
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Fig. 3. Inulin clearance (C,,,) in Groups 1(0), 2 (•), and 3 (A) during
baseline and experimental periods, Values are expressed as means 1
SEM; * P < 0.05 vs. baseline, t P < 0.05 vs. group 2, P < 0.05 vs.
group 3.
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Fig. 4. Hydraulic pressures in descending vasa recta (DVR) in Groups
1 (0), 2 (I), and 3 (A) during baseline and experimental periods.
Values are expressed as means I sEM; * P < 0.05 vs. baseline, t P <
0.05 vs. group 2.
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Fig. 5. Hydraulic pressures in ascending vasa recta (A VR) in Groups I
(0), 2 (S), and 3 (A) during baseline and experimental periods. Values
are expressed as means I SEM; * P < 0.05 vs. baseline, t P< 0.05 vs.
group 2, P < 0.05 vs. group 3.
duced the high rate of V observed with ANP infusion in Group
1 (from 1.3 0.2 to 8.3 0.9 pi/min, P < 0.05). UNa also
increased significantly (from 51 3 to 97 5 mEq/liter), but
this increase was of a significantly lesser magnitude than that
achieved during ANP infusion in Group 1. This resulted in a less
impressive increase in UNaV (Fig. 1). C1 (Fig. 3) remained
relatively stable, in contrast to the rise observed in Group 1.
AP also fell slightly but significantly by 6 mm Hg (Fig. 2). CPAH
remained essentially unchanged (1.47 0.06 and 1.41 0.05
mI/mm, baseline and experimental period, respectively).
During infusion of furosemide, hydraulic pressures in tubule
elements were increased significantly as in Group 1 by approx-
imately 2 mm Hg, on average in loops of Henle from 7.3 0.3
to 9.2 0.4 mm Hg, at the collecting duct base from 4.5 0.2
to 6.3 0.4 mm Hg, and at the mid-portion of the collecting
duct from 2.8 0.3 to 4.4 0.3 mm Hg. In contrast to Group
1 animals, however, the increment in vasa recta hydraulic
pressures during furosemide administration (Figs. 4 and 5) was
no greater in magnitude than that observed in tubule elements,
increasing on average also by approximately 2 mm Hg in
descending vasa recta (from 8.4 0.5 to 10.8 1.3 mm Hg) and
in ascending vasa recta (from 7.8 0.4 to 10.0 1.0 mm Hg).
Likewise, continuous monitoring of hydraulic pressure in a
descending vas rectum during initiation and continued admin-
istration of furosemide revealed an increase from 8.5 to only 9.5
mm Hg within the initial two minutes of study, in contrast to the
prompt and more marked rise in vascular hydraulic pressure
observed upon infusion of ANP in Group 1.
Group 3. Infusion of ANP at an equivalent dose as in Group
1, but without commencing replacement of plasma volume
losses until the diuresis was well established, produced a
markedly blunted natriuretic response (Fig. 1), approximately
10% of the increment observed in Group 1. The increase in V
(from 2.2 0.4 to 3.7 0.5 d/min, P <0.05) was significantly
less than that which ocurred in both Groups 1 and 2. The rise in
UNa (from 56 6 to 107 17, P < 0.05) was also of
substantially lesser magnitude than in Group 1, and resembled
the increment seen during furosemide infusion. AP fell signifi-
cantly, as occurred in the other two groups, but by a numeri-
cally greater amount of 17 mm Hg (Fig. 2). There was near-
constancy of C1>, during ANP infusion in Group 3 (Fig. 3), in
contrast to the rise in C1. in Group 1. Also in contrast to the
stable renal plasma flow rate in Groups 1 and 2, there was a
reduction in CPAH (from 1.36 0.06 to 1.2 0.06, P < 0.05).
The pattern of changes induced by ANP in hydraulic pres-
sures in vasa recta were also different in rats in which plasma
volume was maintained as compared to rats in which plasma
volume replacement was delayed. Instead of the marked in-
creases observed in Group 1 rats, Group 3 rats exhibited small
increments in both descending and ascending vasa recta (Figs.
4 and 5), a response indistinguishable from that evoked by
furosemide. The slight increase observed in tubule hydraulic
pressures of Group 3 animals was similar to that ocurring in the
previous two groups. Average pressures in the loop of Henle
rose from 8.3 0.5 to 9.5 0.5 mm Hg, at the base of the
collecting duct from 4.4 0.1 to 5.7 0.2 mm Hg, and in the
mid-portion of the collecting duct from 2.8 0.2 to 4.4 0.2
mm Hg.
The calculated postglomerular plasma oncotic pressure
changes between baseline and experimental periods were as
follows: Group 1: +2.95 mm Hg, Group 2: —0.57 mm Hg, and
Group 3: +3.65 mm Hg.
Discussion
Alterations in medullary hemodynamics have been consid-
ered to play a role in the regulation of renal sodium and water
excretion [181. The ability of renal vasodilators, such as acetyl-
choline and bradykinin, to cause natriuresis and diuresis has
been correlated, in part, with medullary hemodynamic events.
These include a shift in distribution of intrarenal blood flow
toward inner cortex [191 and an increase in papillary plasma
flow rate [20]. However, the precise interplay and relative
importance of these factors in the control of intravascular
volume have been difficult to define.
ANP has potent natriuretic and diuretic properties, acting as
a preferential renal vasodilator [21, 221. Its effect on the
intrarenal vasculature is similar to that of previously studied
renal vasodilators. Infusion of atrial peptides was associated
with a shift in the distribution of renal blood flow from outer to
juxtamedullary cortex and an increase in postglomerular plasma
flow rate, as determined by microsphere and papillary 125I
albumin uptake techniques [3, 6]. Papillary blood flow has also
been shown to increase, as measured with a laser-Doppler
flowmeter, within two minutes of infusion of synthetic ANP
[10]. Vasa recta blood flow was augmented when measured by
fluorescence videomicroscopy 45 minutes after initiation of
ANP infusion [11]. These findings, taken together with the
observed inhibition by ANP of collecting duct sodium reabsorp-
tion in vivo [7], point to inner medullary hemodynamic events
as important determinants of the ANP-induced natriuresis and
diuresis.
The mechanism by which vasodilators increase renal sodium
and water excretion has been attributed, in part, to alterations
in peritubular capillary Starling forces [23], such that reductions
in preglomerular vasomotor tone allows transmission of a
greater fraction of systemic pressure to glomerular and post-
glomerular peritubular capillaries In concert with this proposed
mechanism, increasing renal perfusion pressure during con-
comittant ANP infusion markedly potentiated the attendant
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natriuresis and diuresis [161. In contrast, raising the post-
glomerular vascular oncotic pressure effectively prevented the
ANP-induced natrjuresjs and diuresis [16]. These observations
indicate that peritubular capillary Starling forces can be impor-
tant modulators of the ANP-induced natriuretic and diuretic
effects.
Therefore, in view of the aforementioned effects of ANP on
inner medullary hemodynamics, we sought to determine the
hydraulic pressures in inner medullary structures in response to
ANP and to compare them with the actions of a direct epithelial
sodium transport inhibitor, furosemide, and to ANP adminis-
tration in a setting which resulted in a blunted natriuresis.
Infusion of ANP in euvolemic Group 1 rats resulted in
marked natriuresis and diuresis. Hydraulic pressures in tubule
elements of the exposed renal papilla increased by approxi-
mately 2 mm Hg, an increment which closely matched the rise
in proximal tubule hydraulic pressure observed previously in
superficial cortex [21]. The rise in vasa recta hydraulic pres-
sures during infusion of ANP in this group was much more
marked, however, averaging approximately threefold higher
than that observed in tubule elements. The presence of this
pressure differential between the vascular and tubule elements
indicates that this effect was not secondary to increases in loop
transport or tubule fluid flow rates. Of particular note, this rise
in papillary vascular pressures also exceeded the magnitude of
increase in efferent arteriolar hydraulic pressure found in su-
perficial cortex, which averaged only 2 mm Hg [211, thereby
providing direct evidence for a preferential vasodilatory re-
sponse to ANP infusion in medullary microvasculature.
In contrast to the effects of ANP and other potent vasodila-
tors, studies of intrarenal blood flow distribution during furose-
mide infusion have revealed increases in flow only to mid-
cortical areas, without enhancement in the juxtamedullary
region [24]. Indeed, postglomerular plasma flow rate in the
juxtamedullary region, as determined by papillary 1251-albumin
uptake in vivo, is reduced during furosemide infusion [25]. It is
therefore not surprising that, in the present studies, furosemide
infusion failed to preferentially augment vasa recta hydraulic
pressures in Group 2 animals. In contrast to the pressure
differential occurring between the vascular and tubule elements
during ANP infusion in Group 1, administration of furosemide
led to an approximately equal increment in hydraulic pressures
(—2 mm Hg) in all medullary vascular and tubule structures.
This small increment in vascular hydraulic pressures may have
been due simply to a furosemide-induced increase in tubule
pressures, in a manner analogous to that observed in superficial
proximal tubules and adjacent peritubular capillaries following
graded elevations of ureteral pressure or during mannitol diure-
sis [13]. Indeed, administration of furosemide has been shown
to elevate hydraulic pressures in superficial proximal tubules
and peritubular capillaries even when glomerular capillary
hydraulic pressure remained stable and single nephron GFR
declined [26]. Although the possibility of a vascular effect of
furosemide independent of this agent's ability to augment
tubule fluid flow rates cannot be excluded in the present study,
the data serve to reinforce the concept that such an independent
vascular effect must occur for ANP when its full hemodynamic
effects are manifested.
Pre-renal arterial clamping has been demonstrated to blunt or
abolish the ANP-induced natriuresis [1, 4, 91, an effect which
has been ascribed to impeding the rise in GFR [1]. However,
lowering renal perfusion pressure not only abolishes the rise in
GFR but would also interfere with the occurrence of other
hemodynamic events and, by itself, results in a lowering in
renal sodium excretion [4, 9]. In the present study, failure to
restore plasma volume during ANP administration in Group 3
rats was associated with unchanged GFR and a fall in RPF, a
different whole kidney hemodynamic response than in Group 1.
The natriuresis was also markedly attenuated (Fig. 1), consist-
ing of approximately 10% of the increment in UNaV observed in
Group 1 animals. In concert with the diminished natriuresis, the
preferential increase in vasa recta hydraulic pressures also
failed to occur. Instead, the hydraulic pressure increase in vasa
recta was of the same magnitude as the rise in tubule hydraulic
pressure, as occurred with furosemide infusion. The dimin-
ished, although significant, natriuretic response by Group 3 rats
indicates that ANP possesses natriuretic actions independent of
its effects on inner medullary and glomerular hemodynamics.
This blunted natriuresis was of the same magnitude as that
obtained when pre-renal arterial constriction was used to lower
the GFR to pre-ANP infusion levels [11 and may represent the
contribution of direct inhibition of sodium transport by the
inner medullary collecting duct [8] in the absence of increased
delivery to this segment. Thus, the niedullary hemodynamic
effects of ANP represent one of several factors contributing to
natriuresis and diuresis, as discussed below. The observed
lessening of the natriuretic and vascular effects in Group 3
might be due to the fall in renal perfusion pressure below 90 mm
Hg, the level used in previous studies to impede renal hemo-
dynamic effects of ANP [1, 4, 9]. The results obtained in this
group underscore the importance of maintenance of plasma
volume for full expression of the hemodynamic, and therefore,
natriuretic and diuretic effects.
It is reasonable to assume that the pressure differential
occurring between vascular and tubule elements in the papilla
during ANP infusion in Group 1 would serve to limit fluid
removal from the local interstitiurn, but only insofar as these
increments in vascular hydraulic pressure exceeded any offset-
ting increases in vasa recta oncotic pressure. Although direct
measurements of vasa recta oncotic pressure during infusion of
ANP are not currently available, the calculated efferent arteri-
olar plasma oncotic pressure increased by less than 3 mm Hg in
Group 1 rats, a value similar to that obtained for the superficial
cortical efferent arteriolar oncotic pressure change [21]. This
value would therefore serve as the upper limit for post-
glomerular plasma oncotic pressure change during the euvole-
mic ANP infusion studies. However, if the filtration fraction
(FF) in deep glomeruli during ANP infusion falls with respect to
that in superficial glomeruli, as occurs with infusions of other
renal vasodilatory agents [27], and during a state known to be
associated with ANP release [28], volume expansion with saline
solutions [20, 30], there may be an even smaller, if any, increase
in oncotic pressure within vasa recta. In addition, the prefer-
ential increase in blood flow to the deep nephron vasculature
induced by ANP in the face of constant whole kidney plasma
flow [4, 10, 11], suggests that indeed deep glomeruli may have
a lower FF than superficial glomeruli during ANP infusion. It
therefore appears unlikely that alterations in vasa recta oncotic
pressure could offset the hydraulic pressure elevations ob-
served in Group 1 rats. Moreover, since vasa recta are
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postglomerular capillaries, this unopposed increase in hydraulic
pressure is likely representative of the entire postglomerular
circulation surrounding juxtamedullary nephrons, and could
therefore limit fluid reabsorption at other sites in this nephron
population as well. These events could explain the finding of
increased fractional excretion of lithium during ANP infusion in
intact animals [5, 61, despite the lack of inhibitory effect of this
peptide on absolute sodium reabsorption by superficial proxi-
mal tubules in vivo [1] or by proximal straight or convoluted
tubules from either superficial orjuxtamedullary cortex in vitro
[31]. Indeed, sodium delivery to the end-descending limb of
juxtamedullary nephrons was increased by ANP infusion de-
spite constant juxtamedullary single nephron GFR [32].
Videomicroscopic studies of the exposed renal papilla in vivo
have demonstrated significant increases in vasa recta blood flow
in response to infusion of ANP but revealed that such incre-
ments may lag behind the onset of natriuresis and diuresis,
suggesting that the initial natriuretic effect of ANP resulted
from actions other than the increase in blood flow [111. This
study showed a doubling of UNaV at two minutes after infusion
of ANP and had increased further to fourfold over baseline
values when measured at 45 minutes, at a time when vasa recta
blood flows were significantly increased [11]. Thus, natriuresis
was markedly enhanced at a time when vasa recta hydraulic
pressure would have been expected to be highest. Moreover, as
soon as two minutes following intravenous infusion of ANP, a
significant rise in papillary blood flow has been demonstrated by
other investigators in rats with exposed renal papilla using a
laser-Doppler flowmeter technique [10]. The hydraulic pressure
elevations in descending and ascending vasa recta in the present
study were documented at 10 to 30 minutes after initiation of the
ANP infusion, at a time when peak natriuresis had already been
achieved. However, hydraulic pressure within a descending vas
rectum in the present study, when measured continuously by an
indwelling micropipette, was found to increase by several mm
Hg within 90 seconds of initiating the systemic ANP infusion, at
a time which appeared to coincide with the onset of diuresis.
This indicates that changes in medullary hemodynamics may
also be an important factor during the initial, as well as the
maintenance, phases of the natriuretic response.
The findings in the present study offer insight not only into
the mechanisms contributing to the natriuresis and diuresis
induced by ANP but also concerning the markedly hypernatric
character of the final urine. As shown in this study and
previously, infusion of ANP augments GFR [1,2, 16,21], which
not only enhances delivery of tubule fluid and solutes to more
distal nephron segments [2], but also preserves salt transport in
the medullary thick ascending limb of Henle [8], the latter
promoting maintenance of a medullary interstitium more rich in
sodium than is observed with administration of loop-active
agents, such as furosemide [331. ANP infusion also results in an
elevation of vasa recta hydraulic pressure, almost certainly in
excess of increments in oncotic pressure, thereby rendering
local Starling forces less favorable for capillary fluid reabsorp-
tion, not only in the papilla, but in the entire postglomerular
microcirculation surrounding juxtamedullary nephrons. Fur-
thermore, the imbalance of hydraulic pressures between vascu-
lar and tubule elements could promote recycling of the rela-
tively hypernatric papillary interstitial fluid favoring convective
movement of sodium to adjacent collecting ducts. Although the
medullary collecting duct of the golden hamster under antidi-
uretic conditions has been shown to have a high electrical
resistance [34], the permeability of the inner medullary collect-
ing duct during diuretic or volume expanded conditions is
unknown. Indeed, preliminary in vitro studies have suggested
that ANP may actually facilitate secretion of sodium by the
inner medullary collecting duct [35]. This movement of sodium
and water into the collecting duct lumen could occur through
paracellular channels formed by permeable tight junctions
known to be present in inner medullary collecting duct epithelia
[361. This possible recycling action by ANP, together with
direct inhibition of active sodium transport in inner medullary
collecting duct cells, would thereby confirm in vivo indications
that ANP alters sodium transport in these terminal nephron
segments [7]. Thus, the combination of enhanced distal sodium
delivery through both an increase in GFR and unfavorable
balance of vasa recta Starling forces, possible recycling of
sodium from relatively hypernatric papillary interstitium to
collecting duct lumen, and direct effects on inner medullary
collecting duct sodium transport, all contribute to the large
magnitude and hypernatric character of ANP-induced natriure-
sis and diuresis.
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